🇪🇺 Rimegepant/BHV3000 in European Union

Rimegepant/BHV3000 (rimegepant-bhv3000) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Rimegepant/BHV3000 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in European Union

Frequently asked questions

Is Rimegepant/BHV3000 approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Rimegepant/BHV3000 in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.